Featured Clinical Trial: Targeting Tumor Metabolism in Papillary Kidney Cancers - NCI Cancer Bulletin PDF Print
NCI Cancer Bulletin
Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.